Clinical Trials Browser

NETWORK × Rectal Neoplasms × durvalumab × Clear all

NCT03102047 2022-04-20

Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms